ICON Establishes University Scholarship Programme to Provide Increased Opportunities for Underrepresented Groups to Study STEM-Related Courses
Dublin, Ireland – 22 June 2022 – ICON plc, (NASDAQ: ICLR) a global
provider of drug and device development and commercialisation services
to pharmaceutical, biotechnology, medical device, and government
organisations, today announces that it has established a scholarship
programme to provide students from underrepresented groups increased
opportunities to access third level education.
More info >> |